Inventor · disambiguated record
Olivier Leger
Also filed as: LEGER OLIVIER · LEGER OLIVIER J · LÉGER OLIVIER
64 granted patents·24 pending applications·1,301 citations·filing 1995–2024
99Inventor score
Top patents by PatentIndex Score
88 records- 0198US7728114B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Jun 1, 2010·260 cites·25 claims
- 0297US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0397US8609822B2Neutralizing antibodies and methods of use thereofELSON GREG·Filed 2012·Granted Dec 17, 2013·48 cites·4 claims
- 0497US5840299AHumanized antibodies against leukocyte adhesion molecule VLA-4ATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 24, 1998·323 cites·29 claims
- 0596US10280226B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted May 7, 2019·17 cites·30 claims
- 0696US10155818B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2015·Granted Dec 18, 2018·17 cites·4 claims
- 0796US9624298B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2012·Granted Apr 18, 2017·76 cites·35 claims
- 0894US10487147B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Nov 26, 2019·19 cites·25 claims
- 0994US8715669B2Anti-IL-17A/IL-17F cross-reactive antibodiesMASTERNAK KRZYSZTOF·Filed 2011·Granted May 6, 2014·32 cites·19 claims
- 1094US8246958B2Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodiesBENDIG MARY M·Filed 2008·Granted Aug 21, 2012·56 cites·9 claims
- 1193US10301384B2Antibodies to IL-15CALYPSO BIOTECH SA·Filed 2015·Granted May 28, 2019·18 cites·11 claims
- 1293US8034344B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2009·Granted Oct 11, 2011·19 cites·6 claims
- 1393US7700098B2Anti-interferon gamma antibodies and methods of use thereofNOVIMMUNE SA·Filed 2006·Granted Apr 20, 2010·19 cites·9 claims
- 1493US7674884B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Mar 9, 2010·15 cites·3 claims
- 1593US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 1693US6455677B1FAPα-specific antibody with improved producibilityBOEHRINGER INGELHEIM INT·Filed 1999·Granted Sep 24, 2002·103 cites·19 claims
- 1791US7786268B2Anti-IP-10 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2008·Granted Aug 31, 2010·14 cites·11 claims
- 1890US10759862B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·3 cites·6 claims
- 1989US9682142B2Anti-interferon gamma antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jun 20, 2017·9 cites·10 claims
- 2089US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 2188US10800849B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Oct 13, 2020·2 cites·26 claims
- 2288US9688755B2Fc receptor-binding polypeptides with modified effector functionsNOVIMMUNE SA·Filed 2013·Granted Jun 27, 2017·8 cites·7 claims
- 2388US8771697B2Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodiesMASTERNAK KRZYSZTOF·Filed 2012·Granted Jul 8, 2014·10 cites·17 claims
- 2488US8551478B2Anti-CD3 antibodies and methods of use thereofMACH BERNARD·Filed 2010·Granted Oct 8, 2013·14 cites·14 claims
- 2587US10577426B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Mar 3, 2020·3 cites·21 claims
- 2685US11884724B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Jan 30, 2024·1 cites·14 claims
- 2785US11130806B2Antibodies to IL-15 and uses thereofCALYPSO BIOTECH SA·Filed 2019·Granted Sep 28, 2021·3 cites·16 claims
- 2885US10759856B2Anti-PD-L1 antibodies and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Sep 1, 2020·2 cites·21 claims
- 2985US9850304B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Dec 26, 2017·5 cites·3 claims
- 3085US8168410B2Anti-IGF-IR antibodies and uses thereofGOETSCH LILIANE·Filed 2011·Granted May 1, 2012·4 cites·14 claims
- 3185US8101180B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofGOETSCH LILIANE·Filed 2009·Granted Jan 24, 2012·5 cites·12 claims
- 3285US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 3384US11560437B2Stable multispecific antibodiesBIOMUNEX PHARMACEUTICALS·Filed 2018·Granted Jan 24, 2023·4 cites·14 claims
- 3484US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 3584US10829559B2Anti-GITR antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Nov 10, 2020·1 cites·8 claims
- 3684US9828430B2Anti-IL-6/IL-6R antibodiesNOVIMMUNE SA·Filed 2016·Granted Nov 28, 2017·3 cites·4 claims
- 3784US8258267B2Human anti-IP-10 antibodies uses thereofFISCHER NICOLAS·Filed 2008·Granted Sep 4, 2012·5 cites·7 claims
- 3884US7435802B2Humanized anti-VLA4 immunoglobulinsELAN PHARACEUTICALS INC·Filed 2004·Granted Oct 14, 2008·21 cites·1 claims
- 3983US9234034B2Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodiesNOVIMMUNE SA·Filed 2012·Granted Jan 12, 2016·4 cites·5 claims
- 4082US8546539B2Fc receptor-binding polypeptides with modified effector functionsELSON GREG·Filed 2008·Granted Oct 1, 2013·4 cites·7 claims
- 4182US2023039577A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 4281US10759858B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·1 cites·14 claims
- 4380US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 4480US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 4580US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 4679US8337849B2Anti-IL6/IL-6R antibodiesFERLIN WALTER·Filed 2011·Granted Dec 25, 2012·4 cites·5 claims
- 4778US10023646B2Neutralizing antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Jul 17, 2018·1 cites·8 claims
- 4877US8105595B2Methods of using neutralizing anti-TLR4/MD2 antibodiesELSON GREG·Filed 2010·Granted Jan 31, 2012·2 cites·8 claims
- 4976US11505616B2Binding molecules to CD38 and PD-L1BIOMUNEX PHARMACEUTICALS·Filed 2017·Granted Nov 22, 2022·1 cites·7 claims
- 5076US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Olivier Leger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →